original ) (raw )The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety
Muhammad Akram Phd
Journal of Neurochemistry, 2001
View PDFchevron_right
Continuous MPTP intoxication in the Göttingen minipig results in chronic parkinsonian deficits
Arne Møller
Acta neurobiologiae experimentalis, 2016
View PDFchevron_right
Classic toxin-induced animal models of Parkinson’s disease: 6-OHDA and MPTP
sanjeevi suganthi krishnan
Cell and Tissue Research, 2004
View PDFchevron_right
Biochemical Events in the Development of Parkinsonism Induced by 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine
Rona Ramsay
Journal of Neurochemistry, 1987
View PDFchevron_right
Search for neurotoxins structurally related to 1-methyl-4-phenylpyridine (MPP+) in the pathogenesis of Parkinson's disease
Carol Markey
Brain Research, 1992
View PDFchevron_right
MPTP-induced mouse model of Parkinson’s disease: A promising direction of therapeutic strategies
Che Norma Mat Taib
Bosnian Journal of Basic Medical Sciences, 2020
View PDFchevron_right
Toxin-induced models of Parkinson’s disease
Celine Perier
NeuroRX, 2005
View PDFchevron_right
MPTP-induced mouse model of Parkinson’s disease: A promising direction for therapeutic strategies
Che Norma Mat Taib
Bosn J Basic Med Sci, 2020
View PDFchevron_right
The Parkinsonian Neurotoxin 1-Methyl-4-Phenylpyridinium (MPP + ) Mediates Release of l -3,4-Dihydroxyphenylalanine ( l -DOPA) and Inhibition of l -DOPA Decarboxylase in the Rat Striatum: A Microdialysis Study
Glenn Dryhurst
Chemical Research in Toxicology, 2003
View PDFchevron_right
Neurotoxin models and treatments of Parkinson’s disease
Sanjar Alam
International journal of health sciences
View PDFchevron_right
The risk is in the air: Intranasal administration of MPTP to rats reproducing clinical features of Parkinson's disease
Jorge Florio
Experimental Neurology, 2006
View PDFchevron_right
Toxin-Induced Parkinson’s Disease Models
gokul krishna
Neuro – Open Journal, 2017
View PDFchevron_right
Stable parkinsonian syndrome and uneven loss of striatal dopamine fibres following chronic MPTP administration in baboons
Philippe Hantraye
Neuroscience, 1993
View PDFchevron_right
Mechanism of the neurotoxicity of MPTP: An update
Rona Ramsay
Febs Letters, 1990
View PDFchevron_right
Mechanism of the neurotoxicity of MPTP
Rona Ramsay
FEBS Letters, 1990
View PDFchevron_right
Synthetic and Natural Environmental Compounds as Potential Facilitators of Mptp-Induced Parkinsonism
Celia Dodd
2009
View PDFchevron_right
Aging of the dopaminergic system and motor behavior in mice intoxicated with the parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Annick Prigent , Claude Sebban , Jean Mariani
Journal of Neurochemistry, 2012
View PDFchevron_right
Spinal cord degeneration in C57BL/6N mice following induction of experimental parkinsonism with MPTP
Supriti Samantaray
Journal of Neurochemistry, 2008
View PDFchevron_right
The parkinsonism-inducing drug 1-methyl-4-phenylpyridinium triggers intracellular dopamine oxidation. A novel mechanism of toxicity
Julie Lotharius
The Journal of biological chemistry, 2000
View PDFchevron_right
Potential environmental neurotoxins related to 1-methyl-4-phenylpyridinium: Selective toxicity of 1-methyl-4-(4′-acetamidophenyl)-pyridinium and 1-methyl-4-cyclohexylpyridinium for dopaminergic neurons in culture
Simon Efange
Experimental Neurology, 1990
View PDFchevron_right
Experimental Animal Models of Parkinson’s Disease: A Neurotoxin Overview
Dr. Rahul Deshmukh , Ashwani Kumar
View PDFchevron_right
MPTP-induced Parkinsonism in minipigs: A behavioral, biochemical, and histological study
Arne Møller
Neurotoxicology and Teratology
View PDFchevron_right
Neurotoxin-based models of Parkinson's disease
Celine Perier
Neuroscience, 2012
View PDFchevron_right
Behavioral changes are not directly related to striatal monoamine levels, number of nigral neurons, or dose of parkinsonian toxin MPTP in mice
Charles Cohen-Salmon
Neurobiology of Disease, 2003
View PDFchevron_right
Behavioral Tests in Neurotoxin-Induced Animal Models of Parkinson's Disease
Dr. E. Maruthi Prasad
Antioxidants, 2020
View PDFchevron_right
IV. Differences in the metabolism of MPTP in the rodent and primate parallel differences in sensitivity to its neurotoxic effects
Sanford Markey
Life Sciences, 1985
View PDFchevron_right
Neurotoxic_in_vivo_models_of_Parkinson_s_disease-_recent_advances
Franklyn Rocha Cabrero
View PDFchevron_right
Influence of intranasal exposure of MPTP in multiple doses on liver functions and transition from non-motor to motor symptoms in a rat PD model
Dr. Kavina Ganapathy
Naunyn-Schmiedeberg's Archives of Pharmacology, 2019
View PDFchevron_right